Prime Medicine, Inc. is a champion in the biomedical sector, specialising in the development of innovative gene editing therapies. The company operates globally, striving to tackle genetic diseases by targeting the root cause.
Prime Medicine, Inc. is a part of the wider medical research and development industry that uses ground-breaking techniques such as base editing to create medical breakthroughs and provide patients with transformative treatments. Prime has also partnered with Beam Therapeutics.
Track the share price of PRME by adding it to your eToro watchlist.